According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.38 Billion. In 2023 the company made an earning of -HK$1.77 Billion, an increase over its 2022 earnings that were of -HK$1.91 Billion. The earnings displayed on this page is the company's Pretax Income.